Luckenwalde
Germany
8
2017-06-22
8
2019-01-29
These are the the leading inventors for applications assigned to CELLTREND GMBH:
CELLTREND GMBH based in Luckenwalde, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Diagnosis of cancer by detecting auto-antibodies against vascular endothelial growth factor receptor (VEGFR)
#2 | 2017-06-15 ✅ Patent 10,732,184 granted on 2020-08-04Diagnosis of cancer by detecting auto-antibodies against PAR1
#3 | 2017-01-12 ✅ Patent 10,203,343 granted on 2019-02-12Diagnosis of cancer by detecting auto-antibodies against epidermal growth factor (EGF)
#4 | 2017-01-12 ✅ Patent 10,739,346 granted on 2020-08-11Diagnosis of cancer by detecting auto-antibodies against EGF-receptor
#5 | 2013-10-10 ✅ Patent 8,846,324 granted on 2014-09-30In vitro method for diagnosing or predicting hypertension and/or early-stage cardiovascular end-organ damage by determining the concentration of soluble prorenin receptor
#6 | 2013-03-14 ✅ Patent 8,999,338 granted on 2015-04-07Method for diagnosis for multiple sclerosis involving anti1-receptor antibody
#7 | 2010-04-22 ✅ Patent 8,425,877 granted on 2013-04-23Method for diagnosis of systemic sclerosis involving an anti-AT1-receptor antibody
#8 | 2010-03-25 ✅ Patent 8,592,164 granted on 2013-11-26Method for diagnosis of a disease involving an anti-endothelin-receptor antibody
Also check out CELLTREND GMBH's (Luckenwalde, Germany) applicant profile with 7 patent applications submitted.
14000 ⎘